{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:11:33Z","timestamp":1777392693827,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014180","name":"Junta de Castilla y Le\u00f3n","doi-asserted-by":"publisher","award":["BIO\/BU06\/14"],"award-info":[{"award-number":["BIO\/BU06\/14"]}],"id":[{"id":"10.13039\/501100014180","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008431","name":"Consejer\u00eda de Educaci\u00f3n, Junta de Castilla y Le\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008431","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.parkreldis.2021.09.014","type":"journal-article","created":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T12:10:17Z","timestamp":1632226217000},"page":"167-172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Plasma acyl-carnitines, bilirubin, tyramine and tetrahydro-21-deoxycortisol in Parkinson's disease and essential tremor. A case control biomarker study"],"prefix":"10.1016","volume":"91","author":[{"given":"Silvia M.","family":"Albillos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olimpio","family":"Montero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Calvo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berta","family":"Solano-Vila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 M.","family":"Trejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Cubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.parkreldis.2021.09.014_bib1","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1016\/j.parkreldis.2015.09.048","article-title":"Biomarkers in Parkinson's disease: advances and strategies","volume":"22","author":"Delenclos","year":"2016","journal-title":"Park. Relat. Disord."},{"issue":"8","key":"10.1016\/j.parkreldis.2021.09.014_bib2","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1001\/archneur.63.8.1100","article-title":"Common misdiagnosis of a common neurological disorder: how are we misdiagnosing essential tremor?","volume":"63","author":"Jain","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.parkreldis.2021.09.014_bib3","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1017\/S1355617716000503","article-title":"Biomarkers in prodromal Parkinson disease: a qualitative review","volume":"22","author":"Cooper","year":"2016","journal-title":"J.\u00a0Int. Neuropsychol. Soc."},{"key":"10.1016\/j.parkreldis.2021.09.014_bib4","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/ane.12590","article-title":"Cerebrospinal fluid biomarkers for Parkinson's disease - a systematic review","volume":"135","author":"Andersen","year":"2017","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.parkreldis.2021.09.014_bib5","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/mds.26578","article-title":"Longitudinal measurements of cerebrospinal fluid biomarkers in Parkinson's disease","volume":"31","author":"Hall","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2021.09.014_bib6","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1212\/WNL.0000000000003663","article-title":"Metabolomic biomarkers as strong correlates of Parkinson disease progression","volume":"88","author":"LeWitt","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2021.09.014_bib7","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/mds.26438","article-title":"The NINDS Parkinson's Disease biomarkers program","volume":"31","author":"Rosenthal","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2021.09.014_bib8","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/mds.26613","article-title":"The BioFIND study: characteristics of a clinically typical Parkinson's disease biomarker cohort","volume":"31","author":"Kang","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2021.09.014_bib9","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/jnnp-2014-309676","article-title":"Identification of novel biomarkers for Parkinson's disease by metabolomics technologies","volume":"87","author":"Hatano","year":"2016","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2021.09.014_bib10","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/mds.26992","article-title":"Metabolic profiling of Parkinson's disease and mild cognitive impairment","volume":"32","author":"Burt\u00e9","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2021.09.014_bib11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2021.09.014_bib12","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: onset, progression and mortality","volume":"17","author":"Hoehn","year":"1967","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2021.09.014_bib13","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1002\/mds.21844","article-title":"Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force","volume":"22","author":"Dubois","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2021.09.014_bib14","first-page":"S7","article-title":"Criteria for the diagnosis of essential tremor","volume":"54","author":"Bain","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2021.09.014_bib15","volume":"vol. 2","author":"Fahn","year":"1987"},{"key":"10.1016\/j.parkreldis.2021.09.014_bib16","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/mds.22007","article-title":"Parkinson's disease-cognitive rating scale: a new cognitive scale specific for Parkinson's disease","volume":"23","author":"Pagonabarraga","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2021.09.014_bib17","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1002\/mds.21596","article-title":"The metric properties of a novel non-motor symptoms scale for Parkinson's disease: results from an international pilot study","volume":"22","author":"Chaudhuri","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2021.09.014_bib18","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/ene.12688","article-title":"Increased bilirubin levels in de novo Parkinson's disease","volume":"22","author":"Moccia","year":"2015","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.parkreldis.2021.09.014_bib19","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1212\/WNL.54.6.1297","article-title":"Evaluation of heme oxygenase-1 as a systemic biological marker of sporadic AD","volume":"54","author":"Schipper","year":"2000","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.parkreldis.2021.09.014_bib20","first-page":"301","article-title":"Crosstalk between mitochrondria and peroxisomes, World","volume":"6","author":"Demarquoy","year":"2015","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.parkreldis.2021.09.014_bib21","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1136\/jnnp.2004.060186","article-title":"Neurodegenerative disorders: Parkinson's disease and Huntington's disease","volume":"76","author":"Hague","year":"2005","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatr."},{"key":"10.1016\/j.parkreldis.2021.09.014_bib22","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1471-4159.2010.07123.x","article-title":"Tryptophan hydrolase 2 aggregates through disulphide cross-linking upon oxidation: possible link to serotonin deficits and non-motor symptoms in Parkinson's disease","volume":"116","author":"Kuhn","year":"2011","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.parkreldis.2021.09.014_bib23","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.redox.2018.10.003","article-title":"Monoamine oxidase-A promotes protective autophagy in human SH-SY5Y neuroblastoma cells through Bcl-2 phosphorylation","volume":"20","author":"Ugun-Klusek","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.parkreldis.2021.09.014_bib24","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3389\/fnmol.2019.00143","article-title":"Monoamine oxidases (MAOs) as priviledged molecular targets in neuroscience: research literature analysis","volume":"12","author":"Yeung","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.parkreldis.2021.09.014_bib25","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1124\/pr.117.015305","article-title":"Trace amines and their receptors","volume":"70","author":"Gainetdinov","year":"2018","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.parkreldis.2021.09.014_bib26","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3389\/fnins.2016.00148","article-title":"Trace amines and the trace amine-associated receptor 1: pharmacology, neurochemistry and clinical implications","volume":"10","author":"Pei","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.parkreldis.2021.09.014_bib27","first-page":"6151","article-title":"Different circulating trace amine profiles in De Novo and treated Parkinson's disease patients","volume":"9","author":"D'Andrea","year":"2019","journal-title":"Nature"},{"issue":"Suppl 1","key":"10.1016\/j.parkreldis.2021.09.014_bib28","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.1016\/S1353-8020(11)70065-7","article-title":"Neuroinflammation in Parkinson's disease","volume":"18","author":"Hirsch","year":"2012","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2021.09.014_bib29","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/nen.0b013e3180517454","article-title":"Analysis of the adrenal gland is useful for evaluating pathology of the peripheral autonomic nervous system in Lewy body disease","volume":"66","author":"Fumimura","year":"2007","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"issue":"17","key":"10.1016\/j.parkreldis.2021.09.014_bib30","doi-asserted-by":"crossref","first-page":"16690","DOI":"10.18632\/aging.103992","article-title":"Metabolic alterations in plasma from patients with familial and idiopatic Parkinson's disease","volume":"12","author":"Yakhine-Diop","year":"2020","journal-title":"Aging"},{"issue":"1","key":"10.1016\/j.parkreldis.2021.09.014_bib31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/metabo11010029","article-title":"Gut microbiota dysbiosis is associated with elevated bile acids in Parkinson's disease","volume":"11","author":"Li","year":"2021","journal-title":"Metabolites"}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802021003436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802021003436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:24:18Z","timestamp":1761179058000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802021003436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":31,"alternative-id":["S1353802021003436"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2021.09.014","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma acyl-carnitines, bilirubin, tyramine and tetrahydro-21-deoxycortisol in Parkinson's disease and essential tremor. A case control biomarker study","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2021.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}